Defunct Company
Total Trials
56
As Lead Sponsor
22
As Collaborator
34
Total Enrollment
1,129,806
NCT03047954
Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis
Phase: Phase 3
Role: Lead Sponsor
Start: Jul 31, 2003
Completion: Dec 31, 2006
NCT01219309
Omega-3/Omega-6 Fatty Acids for Attention-Deficit/Hyperactivity Disorder (ADHD): A Trial in Children and Adolescents
Role: Collaborator
Start: Aug 31, 2004
Completion: Apr 30, 2007
NCT00882414
Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
Phase: Phase 2
Start: Dec 31, 2006
Completion: Jan 31, 2010
NCT00414128
Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
Phase: Phase 2/3
Start: Mar 31, 2007
Completion: Feb 28, 2013
NCT00520780
Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
Start: Apr 30, 2007
Completion: Sep 30, 2009
NCT00706667
Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
Phase: Phase 4
Start: May 31, 2008
Completion: Dec 31, 2012
NCT00746551
Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment
Start: Sep 30, 2008
Completion: Apr 30, 2010
NCT00810030
FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
Start: Oct 31, 2008
NCT00821717
EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart Failure
Start: Dec 31, 2008
Completion: Jan 31, 2011
NCT00824460
Study of Phosphate Levels in Patients With Chronic Kidney Disease
Completion: Mar 31, 2010
NCT00810004
Maintenance Treatment of Iron Deficiency in IBD Patients
Start: Feb 28, 2009
Completion: Oct 31, 2010
NCT01057004
EVIdence Based TreAtment - Heart Failure (EVITA-HF)
Phase: N/A
Completion: Dec 31, 2015
NCT02221752
Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
Start: Jun 30, 2009
Completion: Dec 31, 2011
NCT01245777
Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
Start: Oct 31, 2009
NCT00994318
Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
Start: Dec 31, 2009
Completion: Feb 28, 2014
NCT01100879
Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving Chemotherapy
Start: Mar 31, 2010
Completion: Oct 31, 2011
NCT02557477
Omega 3/6 Fatty Acids for Reading in Children
NCT00978575
Iron Substitution After Upper Gastro-Intestinal Bleeding
Start: Apr 30, 2010
Completion: Apr 30, 2013
NCT01101399
Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy
Start: May 31, 2010
Completion: Nov 30, 2013
NCT01131624
Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant Women
Completion: Apr 30, 2015
NCT01110356
Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing Age
Start: Jun 30, 2010
Completion: Oct 31, 2012
NCT01288651
Iron Deficiency In Pulmonary Hypertension
Start: Jan 31, 2011
Completion: Jan 31, 2013
NCT01913808
Comparing Intravenous and Oral Iron in Postoperative Anemia
NCT01324128
A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis Patients
Start: Mar 31, 2011
NCT01324752
A Drug-Drug Interaction Study of Losartan and PA21
Phase: Phase 1
Completion: Jun 30, 2011
NCT02232906
Switch From Oral Iron to Intravenous Ferric Carboxymaltose in Non-dialysis Chronic Kidney Disease (CKD)
Completion: Sep 30, 2013
NCT01345968
Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
Start: Jun 30, 2011
NCT01394562
Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
Start: Jul 31, 2011
Completion: May 31, 2016
NCT01438359
A Drug-Drug Interaction Study of Furosemide and PA21
Completion: Sep 30, 2011
NCT01452906
A Drug-Drug Interaction Study of Omeprazole and PA21
Start: Sep 30, 2011
NCT01464190
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT01453608
A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
Start: Oct 31, 2011
Completion: Jan 31, 2015
NCT01477411
A Drug-Drug Interaction Study of Digoxin and PA21
Start: Nov 30, 2011
Completion: Jan 31, 2012
NCT01477424
A Drug-Drug Interaction Study of Warfarin and PA21
Completion: Feb 29, 2012
NCT02147795
The German Patient Blood Management Network
Start: Jan 31, 2012
Completion: Dec 31, 2025
NCT01513369
Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency
Start: Aug 31, 2012
Completion: Apr 30, 2019
NCT01820949
Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
Start: Jan 31, 2013
Completion: Sep 30, 2015
NCT02213653
Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
Start: Apr 30, 2013
Completion: Nov 30, 2014
NCT02243735
Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
Start: Nov 30, 2014
Completion: Dec 31, 2019
NCT02125344
A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
Start: Dec 31, 2014
Completion: Jan 30, 2017
NCT01975272
The Use of Iron Therapy for Patients With Anemia After Caesarean Section
Start: Mar 2, 2015
Completion: Jun 21, 2018
NCT02846896
The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
Start: Dec 31, 2015
Completion: Mar 31, 2017
NCT03574311
Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery
Start: Oct 2, 2018
Completion: Dec 31, 2023
NCT03759964
Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
Start: Dec 15, 2018
Completion: Jan 2, 2021
NCT03781089
Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Start: Jun 20, 2019
Completion: Mar 15, 2023
NCT03957187
Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation
Start: Oct 1, 2019
Completion: Aug 31, 2022
NCT04616092
Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
Start: Nov 30, 2020
Completion: Apr 30, 2023
NCT04249648
Hyperkalaemia and Its Impact on Therapy with RAASi
Start: Jul 12, 2021
Completion: Nov 1, 2024
NCT04510792
IMpact of HyPeRkalaemia on ThErapy with Renin AngiotenSin AldoSterone System Inhibitors
Completion: Nov 30, 2024
NCT04903717
Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
Start: Nov 3, 2021
Completion: Feb 6, 2024
NCT05389826
mHealth for Phosphorus Management in CKD.
Start: Jun 1, 2022
Completion: Oct 15, 2023
NCT05415969
CKD-aP Among Adults on Dialysis in Switzerland
Start: Sep 1, 2022
Completion: Oct 9, 2023
NCT05514951
Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
Start: Nov 15, 2022
Completion: Dec 9, 2022
NCT05751772
Improving Knowledge in Heart Failure Inpatient With Therapeutic Education
Start: Dec 13, 2022
Completion: Jan 31, 2024
NCT05786469
Patiromer Trial in CKD Stage IIIB to V
Start: Aug 2, 2023
Completion: Nov 7, 2024
NCT06434025
IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
Start: May 24, 2024
Completion: Nov 24, 2026